A Facile, Protein-Derived Supramolecular Theranostic Strategy for Multimodal-Imaging-Guided Photodynamic and Photothermal Immunotherapy In Vivo

Hong Bo Cheng; Hao Dai; Xiaoqiong Tan; Hao Li; Huihui Liang; Chenyan Hu; Mingwei Huang; Jin Yong Lee; Jing Zhao; Liming Zhou; Yuguang Wang; Liqun Zhang; Juyoung Yoon

doi:10.1002/adma.202109111

A Facile, Protein-Derived Supramolecular Theranostic Strategy for Multimodal-Imaging-Guided Photodynamic and Photothermal Immunotherapy In Vivo

Hong Bo Cheng, Hao Dai, Xiaoqiong Tan, Hao Li, Huihui Liang, Chenyan Hu, Mingwei Huang, Jin Yong Lee, Jing Zhao, Liming Zhou, Yuguang Wang, Liqun Zhang, Juyoung Yoon

Chemistry & Nanoscience

Research output: Contribution to journal › Article › peer-review

36 Scopus citations

Abstract

Theranostic systems that permit both diagnosis and treatment in vivo are highly appealing means by which to meet the demands of precision medicine. However, most such systems remain subject to issues related to complex molecular design and synthesis, potential toxicity, and possible photoactivity changes. Herein, a novel supramolecular theranostic strategy involving biomarker protein activation (BPA) and a host–guest strategy is proposed. To exemplify BPA, a facile “one-for-all” nanotheranostic agent for both albumin detection and cancer treatment is demonstrated, which utilizes a nanoparticulate heavy-atom-free BODIPY dye derivative (B4 NPs). The fluorescence and photoactivity of BODIPY dyes are completely suppressed by aggregation-induced self-quenching in the nanoparticulate state. However, a Balb/c nude mouse model is used to confirm that following the disassembly of injected B4 NPs, BODIPY specifically binds albumin in vivo, accompanied by significantly enhanced biocompatibility and photothermal conversion efficiency. More importantly, this supramolecular host–guest BPA strategy enables the resultant nanoplatform to act as a facile and efficient strategy for photodynamic and photothermal immunotherapy.

Original language	English
Article number	2109111
Journal	Advanced Materials
Volume	34
Issue number	11
DOIs	https://doi.org/10.1002/adma.202109111
State	Published - 17 Mar 2022

Bibliographical note

Funding Information:
H.-B.C., H.D., and X.T. contributed equally to this work. The authors acknowledge the National Natural Science Foundation of China (21502195, 51972003, 21671178, U1704256), the financial supports from Fundamental Research Funds for the Central Universities (11170042105, buctrc202004), Intergovernmental International Cooperation Project of the Ministry of Science and Technology (2018YFE0192500), and Zhongyuan Science and Technology Innovation Leading Talents (214200510017). J.Y. was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2021R1A6A1A10039823). All experimental animal procedures were performed in accordance with the Guidelines for Care and Use of Laboratory Animals of Peking University and approved by the Animal Ethics Committee of Biomedical Ethics Committee of Peking University (the approval number is LA2019078). Note: Hong-Bo Cheng, Jing Zhao, Liming Zhou, and Yuguang Wang were marked as corresponding authors on March 17, 2022, after initial publication online.

Publisher Copyright:
© 2022 Wiley-VCH GmbH

Keywords

cancer therapy
enhanced photothermal efficiency
heavy-atom-free BODIPY
host–guest strategy

Access to Document

10.1002/adma.202109111

Cite this

Cheng, H. B., Dai, H., Tan, X., Li, H., Liang, H., Hu, C., Huang, M., Lee, J. Y., Zhao, J., Zhou, L., Wang, Y., Zhang, L., & Yoon, J. (2022). A Facile, Protein-Derived Supramolecular Theranostic Strategy for Multimodal-Imaging-Guided Photodynamic and Photothermal Immunotherapy In Vivo. Advanced Materials, 34(11), Article 2109111. https://doi.org/10.1002/adma.202109111

@article{7b322f074e334c258ee3bab3eff7a938,

title = "A Facile, Protein-Derived Supramolecular Theranostic Strategy for Multimodal-Imaging-Guided Photodynamic and Photothermal Immunotherapy In Vivo",

abstract = "Theranostic systems that permit both diagnosis and treatment in vivo are highly appealing means by which to meet the demands of precision medicine. However, most such systems remain subject to issues related to complex molecular design and synthesis, potential toxicity, and possible photoactivity changes. Herein, a novel supramolecular theranostic strategy involving biomarker protein activation (BPA) and a host–guest strategy is proposed. To exemplify BPA, a facile “one-for-all” nanotheranostic agent for both albumin detection and cancer treatment is demonstrated, which utilizes a nanoparticulate heavy-atom-free BODIPY dye derivative (B4 NPs). The fluorescence and photoactivity of BODIPY dyes are completely suppressed by aggregation-induced self-quenching in the nanoparticulate state. However, a Balb/c nude mouse model is used to confirm that following the disassembly of injected B4 NPs, BODIPY specifically binds albumin in vivo, accompanied by significantly enhanced biocompatibility and photothermal conversion efficiency. More importantly, this supramolecular host–guest BPA strategy enables the resultant nanoplatform to act as a facile and efficient strategy for photodynamic and photothermal immunotherapy.",

keywords = "cancer therapy, enhanced photothermal efficiency, heavy-atom-free BODIPY, host–guest strategy",

author = "Cheng, {Hong Bo} and Hao Dai and Xiaoqiong Tan and Hao Li and Huihui Liang and Chenyan Hu and Mingwei Huang and Lee, {Jin Yong} and Jing Zhao and Liming Zhou and Yuguang Wang and Liqun Zhang and Juyoung Yoon",

note = "Funding Information: H.-B.C., H.D., and X.T. contributed equally to this work. The authors acknowledge the National Natural Science Foundation of China (21502195, 51972003, 21671178, U1704256), the financial supports from Fundamental Research Funds for the Central Universities (11170042105, buctrc202004), Intergovernmental International Cooperation Project of the Ministry of Science and Technology (2018YFE0192500), and Zhongyuan Science and Technology Innovation Leading Talents (214200510017). J.Y. was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2021R1A6A1A10039823). All experimental animal procedures were performed in accordance with the Guidelines for Care and Use of Laboratory Animals of Peking University and approved by the Animal Ethics Committee of Biomedical Ethics Committee of Peking University (the approval number is LA2019078). Note: Hong-Bo Cheng, Jing Zhao, Liming Zhou, and Yuguang Wang were marked as corresponding authors on March 17, 2022, after initial publication online. Publisher Copyright: {\textcopyright} 2022 Wiley-VCH GmbH",

year = "2022",

month = mar,

day = "17",

doi = "10.1002/adma.202109111",

language = "English",

volume = "34",

journal = "Advanced Materials",

issn = "0935-9648",

publisher = "Wiley-Blackwell",

number = "11",

}

TY - JOUR

T1 - A Facile, Protein-Derived Supramolecular Theranostic Strategy for Multimodal-Imaging-Guided Photodynamic and Photothermal Immunotherapy In Vivo

AU - Cheng, Hong Bo

AU - Dai, Hao

AU - Tan, Xiaoqiong

AU - Li, Hao

AU - Liang, Huihui

AU - Hu, Chenyan

AU - Huang, Mingwei

AU - Lee, Jin Yong

AU - Zhao, Jing

AU - Zhou, Liming

AU - Wang, Yuguang

AU - Zhang, Liqun

AU - Yoon, Juyoung

N1 - Funding Information: H.-B.C., H.D., and X.T. contributed equally to this work. The authors acknowledge the National Natural Science Foundation of China (21502195, 51972003, 21671178, U1704256), the financial supports from Fundamental Research Funds for the Central Universities (11170042105, buctrc202004), Intergovernmental International Cooperation Project of the Ministry of Science and Technology (2018YFE0192500), and Zhongyuan Science and Technology Innovation Leading Talents (214200510017). J.Y. was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2021R1A6A1A10039823). All experimental animal procedures were performed in accordance with the Guidelines for Care and Use of Laboratory Animals of Peking University and approved by the Animal Ethics Committee of Biomedical Ethics Committee of Peking University (the approval number is LA2019078). Note: Hong-Bo Cheng, Jing Zhao, Liming Zhou, and Yuguang Wang were marked as corresponding authors on March 17, 2022, after initial publication online. Publisher Copyright: © 2022 Wiley-VCH GmbH

PY - 2022/3/17

Y1 - 2022/3/17

N2 - Theranostic systems that permit both diagnosis and treatment in vivo are highly appealing means by which to meet the demands of precision medicine. However, most such systems remain subject to issues related to complex molecular design and synthesis, potential toxicity, and possible photoactivity changes. Herein, a novel supramolecular theranostic strategy involving biomarker protein activation (BPA) and a host–guest strategy is proposed. To exemplify BPA, a facile “one-for-all” nanotheranostic agent for both albumin detection and cancer treatment is demonstrated, which utilizes a nanoparticulate heavy-atom-free BODIPY dye derivative (B4 NPs). The fluorescence and photoactivity of BODIPY dyes are completely suppressed by aggregation-induced self-quenching in the nanoparticulate state. However, a Balb/c nude mouse model is used to confirm that following the disassembly of injected B4 NPs, BODIPY specifically binds albumin in vivo, accompanied by significantly enhanced biocompatibility and photothermal conversion efficiency. More importantly, this supramolecular host–guest BPA strategy enables the resultant nanoplatform to act as a facile and efficient strategy for photodynamic and photothermal immunotherapy.

AB - Theranostic systems that permit both diagnosis and treatment in vivo are highly appealing means by which to meet the demands of precision medicine. However, most such systems remain subject to issues related to complex molecular design and synthesis, potential toxicity, and possible photoactivity changes. Herein, a novel supramolecular theranostic strategy involving biomarker protein activation (BPA) and a host–guest strategy is proposed. To exemplify BPA, a facile “one-for-all” nanotheranostic agent for both albumin detection and cancer treatment is demonstrated, which utilizes a nanoparticulate heavy-atom-free BODIPY dye derivative (B4 NPs). The fluorescence and photoactivity of BODIPY dyes are completely suppressed by aggregation-induced self-quenching in the nanoparticulate state. However, a Balb/c nude mouse model is used to confirm that following the disassembly of injected B4 NPs, BODIPY specifically binds albumin in vivo, accompanied by significantly enhanced biocompatibility and photothermal conversion efficiency. More importantly, this supramolecular host–guest BPA strategy enables the resultant nanoplatform to act as a facile and efficient strategy for photodynamic and photothermal immunotherapy.

KW - cancer therapy

KW - enhanced photothermal efficiency

KW - heavy-atom-free BODIPY

KW - host–guest strategy

UR - http://www.scopus.com/inward/record.url?scp=85124460155&partnerID=8YFLogxK

U2 - 10.1002/adma.202109111

DO - 10.1002/adma.202109111

M3 - Article

C2 - 35018682

AN - SCOPUS:85124460155

SN - 0935-9648

VL - 34

JO - Advanced Materials

JF - Advanced Materials

IS - 11

M1 - 2109111

ER -

A Facile, Protein-Derived Supramolecular Theranostic Strategy for Multimodal-Imaging-Guided Photodynamic and Photothermal Immunotherapy In Vivo

Abstract

Bibliographical note

Keywords

Access to Document

Fingerprint

Cite this